Turning Point Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Turning Point Therapeutics generated cash of -$153,885,000, which is less than the previous year. Cash used in financing activities reached the amount of $24,004,000 last year. Net change in cash is therefore -$124,419,000.
Cash Flow
| 2017 | -12.64M | -88K | 44.85M |
|---|---|---|---|
| 2018 | -23.53M | -302K | 79.83M |
| 2019 | -57.75M | -361.07M | 365.99M |
| 2020 | -82.79M | -210.03M | 798.73M |
| 2021 | -153.88M | 5.46M | 24.00M |
TPTX Cash Flow Statement (2017 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
Cash at beginning of period | 554.17M | 48.18M | 101.02M | 45.03M | 12.91M |
Operating activities | |||||
Net income | -236.55M | -157.29M | -72.13M | -24.78M | -16.59M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 3.96M | 2.39M | 1.57M | 138K | 63K |
Stock-based compensation expense | 58.55M | 64.16M | 12.70M | 1.14M | 344K |
| Deferred income tax benefit | 58.55M | 64.16M | 12.70M | 1.14M | 344K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 429K | 3.54M | 903K | -119K | 1.28M |
Cash generated by operating activities | -153.88M | -82.79M | -57.75M | -23.53M | -12.64M |
Investing activities | |||||
Purchases Of Investments | -439.23M | -618.97M | -432.17M | 0 | 0 |
Investments In Property Plant And Equipment | -2.42M | -1.26M | -1.74M | -302K | -88K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 5.46M | -210.03M | -361.07M | -302K | -88K |
Financing activities | |||||
Common Stock Issued | 24.00M | 785.46M | 365.99M | 0 | 63K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -1K | 0 | 0 | 0 |
Cash used in financing activities | 24.00M | 798.73M | 365.99M | 79.83M | 44.85M |
Net Change In Cash | -124.41M | 505.91M | -52.84M | 55.99M | 32.12M |
Cash at end of period | 429.75M | 554.10M | 48.18M | 101.02M | 45.03M |
| Data source | Data source | Data source |